Monica M. Castiglione

Effects of ovarian ablation or suppression on breast cancer recurrence and survival: patient-level meta-analysis of 15 000 women in 23 randomised trials

Rosie Bradley, Jeremy Braybrooke, Mike J Clarke, Robert K. Hills et autres

BACKGROUND: For premenopausal women with oestrogen receptor (ER)-positive early breast cancer, the additional protective effect of ovarian function suppression (OFS, by ablation or drugs) may depend on menopausal status after any chemotherapy, and tamoxifen usage. We assess the effects of OFS on …

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

Manuela Rabaglio, Zhuoxin Sun, Rudolf C. Maibach, Anita Giobbie‐Hurder et autres

ch, us, dk, nz, au, be, hu, fr, gb, it (code pays fourni par la source)

Adjuvant Endocrine Therapy

Manuela Rabaglio, Monica M. Castiglione

ch (code pays fourni par la source)

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII

Per Karlsson, Bernard F. Cole, Karen N. Price, Richard D. Gelber et autres

se, us, au, it, ch (code pays fourni par la source)

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Marco Angelo Colleoni, Zhuoxin Sun, Karen N. Price, Per Karlsson et autres

PURPOSE: Predicting the pattern of recurrence can aid in the development of targeted surveillance and treatment strategies. We identified patient populations that remain at risk for an event at a median follow-up of 24 years from the diagnosis of operable breast cancer. …

Breast Cancer in Younger Women

Manuela Rabaglio, Monica M. Castiglione

ch (code pays fourni par la source)

Isolated Tumor Cells in Sentinel Lymph Nodes of Invasive Breast Cancer: Cell Displacement or Metastasis?

Jean‐Christophe Tille, Pierre Loubeyre, Alexandre Bodmer, Alexandre Rozenholc et autres

The goal of this study was to determine whether the presence of isolated tumoral cells (ITCs) in sentinel lymph nodes (SLNs) after core needle biopsy (CNB) is related to the time interval between CNB and surgery and to histopathologic features of invasive …

ch, us (code pays fourni par la source)

Concordance between Core Needle Biopsy and Surgical Excision Specimens for Tumour Hormone Receptor Profiling According to the 2011 St. Gallen Classification, in Clinical Practice

Pierre Loubeyre, Alexandre Bodmer, Jean‐Christophe Tille, Jean‐François Egger et autres

To focus on and compare the tumor hormone receptor profiles on core needle biopsy (CNB) and subsequent surgical excision specimens in a large clinical series of invasive breast carcinoma patients, with regard to guidelines proposed at the St. Gallen International Expert Consensus …

us, ch (code pays fourni par la source)

Intrinsic subtype and its clinical significance in early node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy.

Ewan K.A. Millar, Alan Stuart Coates, Sandra A. O’Toole, Cristina Selinger et autres

504 Background: Gene expression profiling has identified four main intrinsic subtypes of breast cancer which have distinct clinical behaviours and responses to therapy. A simplified immunohistochemical (IHC) panel can provide meaningful discrimination and help guide patient management. Methods: Using tissue microarrays (TMA) …

au, it, us, ch (code pays fourni par la source)

Preventive therapy for breast cancer: a consensus statement

Jack M. Cuzick, Andrea DeCensi, Banu Arun, Powel H. Brown et autres

gb, it, us, ch, au, de (code pays fourni par la source)

Oncology ESAB 2011

Christine Bouchardy Magnin, Monica Gotta, Laura Rubbia‐Brandt, Monica M. Castiglione et autres

Among the priorities established by the faculty of medicine,up to now, oncology was not represented. However, there have been several recent important structural changes in the University hospitals of Geneva (HUG) that now have created a reassessment of the situation: the creation …

[b]Inhibiteurs[/b] de la PARP : nouvelle arme thérapeutique pour les cancers du sein et de l’ovaire

Alexandre Bodmer, Monica M. Castiglione, Ludivine Mercier-Vogel